- Published on
Emergency and Acute Medicine: Spontaneous Bacterial Peritonitis
Spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid that occurs without an identifiable surgically treatable intra-abdominal source. It is diagnosed when the ascitic fluid polymorphonuclear leukocyte (PMN) count exceeds 250 cells/mm³, typically with a positive culture. Distinguishing SBP from secondary bacterial peritonitis is critical, as mismanagement carries severe consequences—secondary peritonitis requires surgery, while surgical intervention in SBP is associated with high mortality. SBP is common in patients with ascites, particularly those with liver cirrhosis, with an annual incidence of up to 30%.
The condition arises primarily due to bacterial translocation from the gut. Portal hypertension leads to bowel wall edema, allowing intestinal bacteria to migrate into the peritoneal cavity. Additional contributing factors include transient bacteremia, impaired immune defenses, and reduced complement activity. Gastrointestinal bleeding further increases risk by compromising mucosal barriers. Although SBP is most commonly associated with cirrhosis, it can rarely occur in other causes of ascites such as nephrotic syndrome or heart failure. The most frequent pathogens are aerobic gram-negative organisms such as Escherichia coli and Klebsiella, followed by gram-positive organisms like streptococci.
Clinical presentation is often subtle, and up to one-third of patients may be asymptomatic. When symptoms occur, they may include mild diffuse abdominal pain, fever, chills, diarrhea, worsening ascites, or altered mental status. On examination, fever is the most common finding, though cirrhotic patients may have only low-grade elevations in temperature. Abdominal tenderness may be present, but classic peritonitis signs like rigidity are often absent due to the presence of ascitic fluid separating peritoneal layers.
Paracentesis is the cornerstone of diagnosis and should be performed in all patients with ascites and suspected infection. The procedure is safe even in the presence of coagulopathy, except in severe thrombocytopenia. Ascitic fluid analysis includes cell count, culture, and biochemical markers. A PMN count above 250 cells/mm³ confirms the diagnosis, even if cultures are negative. Additional findings may include low protein levels, low glucose, elevated lactate dehydrogenase, and acidic pH. Blood tests are supportive and reflect underlying liver disease rather than the infection itself. Imaging is primarily used to exclude secondary causes such as perforation or abscess.
Management begins with prompt empiric antibiotic therapy after diagnostic paracentesis. Third-generation cephalosporins such as cefotaxime or ceftriaxone are first-line treatments. Alternative regimens include broad-spectrum β-lactam combinations, depending on patient factors. Aminoglycosides and fluoroquinolones are generally avoided due to toxicity and resistance concerns. Intravenous albumin is recommended in high-risk patients to reduce the risk of renal failure and improve survival. Early treatment is essential, as SBP carries significant mortality and may precipitate complications such as hepatorenal syndrome.
All patients with SBP require hospital admission for intravenous antibiotics and monitoring. Intensive care may be necessary for those with septic shock or severe hepatic encephalopathy. Discharge is not appropriate unless SBP has been definitively excluded or the patient refuses admission under carefully selected low-risk conditions. Long-term management often includes prophylactic antibiotics to prevent recurrence, particularly in high-risk individuals.
Key clinical pitfalls include failing to perform early paracentesis, overlooking SBP in patients with minimal symptoms, and not excluding secondary peritonitis. Because presentation can be subtle, a high index of suspicion is essential in any patient with ascites who develops clinical deterioration. Early diagnosis and timely treatment significantly improve outcomes.
Spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid that occurs without an identifiable surgically treatable intra-abdominal source. It is diagnosed when the ascitic fluid polymorphonuclear leukocyte (PMN) count exceeds 250 cells/mm³, typically with a positive culture. Distinguishing SBP from secondary bacterial peritonitis is critical, as mismanagement carries severe consequences—secondary peritonitis requires surgery, while surgical intervention in SBP is associated with high mortality. SBP is common in patients with ascites, particularly those with liver cirrhosis, with an annual incidence of up to 30%.
The condition arises primarily due to bacterial translocation from the gut. Portal hypertension leads to bowel wall edema, allowing intestinal bacteria to migrate into the peritoneal cavity. Additional contributing factors include transient bacteremia, impaired immune defenses, and reduced complement activity. Gastrointestinal bleeding further increases risk by compromising mucosal barriers. Although SBP is most commonly associated with cirrhosis, it can rarely occur in other causes of ascites such as nephrotic syndrome or heart failure. The most frequent pathogens are aerobic gram-negative organisms such as Escherichia coli and Klebsiella, followed by gram-positive organisms like streptococci.
Clinical presentation is often subtle, and up to one-third of patients may be asymptomatic. When symptoms occur, they may include mild diffuse abdominal pain, fever, chills, diarrhea, worsening ascites, or altered mental status. On examination, fever is the most common finding, though cirrhotic patients may have only low-grade elevations in temperature. Abdominal tenderness may be present, but classic peritonitis signs like rigidity are often absent due to the presence of ascitic fluid separating peritoneal layers.
Paracentesis is the cornerstone of diagnosis and should be performed in all patients with ascites and suspected infection. The procedure is safe even in the presence of coagulopathy, except in severe thrombocytopenia. Ascitic fluid analysis includes cell count, culture, and biochemical markers. A PMN count above 250 cells/mm³ confirms the diagnosis, even if cultures are negative. Additional findings may include low protein levels, low glucose, elevated lactate dehydrogenase, and acidic pH. Blood tests are supportive and reflect underlying liver disease rather than the infection itself. Imaging is primarily used to exclude secondary causes such as perforation or abscess.
Management begins with prompt empiric antibiotic therapy after diagnostic paracentesis. Third-generation cephalosporins such as cefotaxime or ceftriaxone are first-line treatments. Alternative regimens include broad-spectrum β-lactam combinations, depending on patient factors. Aminoglycosides and fluoroquinolones are generally avoided due to toxicity and resistance concerns. Intravenous albumin is recommended in high-risk patients to reduce the risk of renal failure and improve survival. Early treatment is essential, as SBP carries significant mortality and may precipitate complications such as hepatorenal syndrome.
All patients with SBP require hospital admission for intravenous antibiotics and monitoring. Intensive care may be necessary for those with septic shock or severe hepatic encephalopathy. Discharge is not appropriate unless SBP has been definitively excluded or the patient refuses admission under carefully selected low-risk conditions. Long-term management often includes prophylactic antibiotics to prevent recurrence, particularly in high-risk individuals.
Key clinical pitfalls include failing to perform early paracentesis, overlooking SBP in patients with minimal symptoms, and not excluding secondary peritonitis. Because presentation can be subtle, a high index of suspicion is essential in any patient with ascites who develops clinical deterioration. Early diagnosis and timely treatment significantly improve outcomes.
0 Comments
